SavingsInvestmentsWealth ManagementAbout UsContact Us
BusinessPersonal
Become a client
Johnson & Johnson (USD)
JNJ
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range139.46 | 141.58
52-Wk Range121.00 | 148.59
Last Close139.56
Mkt Cap (m)367,304.11
Dividend yield2.69%
ISINUS4781601046
Volume6,640,534
Exchange VenueNYS

Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.

Key Information
Price/Earning26.58
Price/Book6.31
Price/Sales4.61
P/CF16.18
Rev Growth (3 year avg)5.20
EPS Growth (3 year avg)0.01
Operating Margin % 24.58
Net Margin %18.75
Return on Equity25.51
Debt/Equity0.51

Legal Documents

Prospectus
en 09/11/2017
Annual Report
en 30/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)71,31274,33170,07471,89076,45081,581
Operating Income (m)18,37720,95918,06521,13618,71420,049
Net Income (m)13,83116,32315,40916,5401,30015,297
Basic EPS4.925.805.566.040.485.70
Avg. Diluted Shares Outstanding (m)2,8772,8642,8132,7892,7452,729
Balance Sheet
USD201320142015201620172018
Current Assets (m)56,40759,31160,21065,03243,08846,033
Non Current Assets (m)76,27671,80873,20176,176114,215106,921
Total Assets (m)132,683131,119133,411141,208157,303152,954
Current Liabilities (m)25,67525,08527,74726,28730,53731,230
Total Liabilities (m)------
Total Equity (m)74,05369,75271,15070,41860,16059,752
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)17,41418,47119,27918,76721,05622,201
Capital Expenditure (m)-3,595-3,714-3,463-3,226-3,279-3,670
Figures are quoted in USD unless stated otherwise
0.82 (0.59%)
$
140.38
Last Price
Savings
Investments
Wealth Management
News and Updates
About Us
Contact Us
Support
Follow Us
© 2019 MeDirect Bank (Malta) plc. All rights reserved.